Bailard’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$123K Buy
26,100
+3,631
+16% +$17.1K ﹤0.01% 735
2025
Q1
$103K Buy
+22,469
New +$103K ﹤0.01% 718
2024
Q1
Sell
-26,300
Closed -$111K 824
2023
Q4
$111K Buy
+26,300
New +$111K ﹤0.01% 684